230 related articles for article (PubMed ID: 8534541)
1. [Chronic liver disease exacerbated during alpha-interferon treatment].
Rodríguez Moreno F; González Reimers CE; Santolaria Fernández F; García Castro C; Martínez Riera A; Batista López N
Rev Esp Enferm Dig; 1995 Nov; 87(11):825-7. PubMed ID: 8534541
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
3. [Chronic active hepatitis: recurrence after long-term immunosuppressive therapy in spite of normal liver histology].
Manns M; Meyer zum Büschenfelde KH; Dienes HP; Dormeyer HH
Z Gastroenterol; 1983 Dec; 21(12):700-8. PubMed ID: 6666186
[TBL] [Abstract][Full Text] [Related]
4. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
5. Interferon and steroid treatment in patients with chronic hepatitis C and antinuclear or anti-liver-kidney microsomal antibodies.
Provenzano G; Almasio P; Fabiano C; Magrin S; Pinzello G; Vaccaro A; Craxì A
Ital J Gastroenterol; 1996 Sep; 28(7):377-80. PubMed ID: 8937938
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic hepatitis.
Lambiase L; Davis GL
Gastroenterol Clin North Am; 1992 Sep; 21(3):659-77. PubMed ID: 1381338
[TBL] [Abstract][Full Text] [Related]
8. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
[TBL] [Abstract][Full Text] [Related]
9. [Autoimmune hemolytic anemia reactivated by alpha-interferon therapy in a case of chronic active C-type hepatitis].
Katayama T; Naitou Y; Kusaka M; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Kobayashi M
Rinsho Ketsueki; 1995 Apr; 36(4):339-46. PubMed ID: 7783339
[TBL] [Abstract][Full Text] [Related]
10. Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia.
Giardini C; Galimberti M; Lucarelli G; Polchi P; Angelucci E; Baronciani D; Erer B; Gaziev D; Piga A; Di Gregorio F; Romeo MA; Mangiagli A; Petrelli E; Muretto P
Bone Marrow Transplant; 1997 Nov; 20(9):767-72. PubMed ID: 9384479
[TBL] [Abstract][Full Text] [Related]
11. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.
Schiano TD; Te HS; Thomas RM; Hussain H; Bond K; Black M
Am J Gastroenterol; 2001 Oct; 96(10):2984-91. PubMed ID: 11693337
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of viral hepatitis].
Rambusch EG; Manns MP
Ther Umsch; 1998 Feb; 55(2):71-6, 78-9. PubMed ID: 9545847
[TBL] [Abstract][Full Text] [Related]
13. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
14. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
[TBL] [Abstract][Full Text] [Related]
15. [Chronic hepatitis: indicators of disease activity].
Masevich TsG; Ermolaeva LG
Ter Arkh; 2000; 72(2):17-8. PubMed ID: 10717917
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.
Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K
Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652
[TBL] [Abstract][Full Text] [Related]
17. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
[TBL] [Abstract][Full Text] [Related]
18. Liver enzyme elevation induced by hyperemesis gravidarum: aetiology, diagnosis and treatment.
Conchillo JM; Pijnenborg JM; Peeters P; Stockbrügger RW; Fevery J; Koek GH
Neth J Med; 2002 Oct; 60(9):374-8. PubMed ID: 12572712
[TBL] [Abstract][Full Text] [Related]
19. Response to treatment with interferon-alfa in patients with chronic hepatitis C and high titers of -M2, -M4 and -M8 antimitochondrial antibodies.
Garrido Palma G; Sánchez Cuenca JM; Olaso V; Pina R; Urquijo JJ; López Viedma B; Bustamante M; Berenguer M; Berenguer J
Rev Esp Enferm Dig; 1999 Mar; 91(3):168-81. PubMed ID: 10231308
[TBL] [Abstract][Full Text] [Related]
20. Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
Martocchia A; Labbadia G; Paoletti V; Gargano S; Grossi A; Trabace S; Musca A; Falaschi P
Neuro Endocrinol Lett; 2001; 22(1):49-52. PubMed ID: 11335880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
